Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000232

EVP, Chief Business Officer sold 11,950 shares at $62.16 ($742,838)

  • EVP, Chief Business Officer acquired 11,950 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Baroldi Joseph EVP, Chief Business Officer 2025-09-09 Option exercise 10b5-1 +11,950 $31.80 $380,010 43,876 D
Baroldi Joseph EVP, Chief Business Officer 2025-09-09 Sale 10b5-1 −11,950 $62.16 $742,838 31,926 D
Derivatives
Baroldi Joseph EVP, Chief Business Officer 2025-09-09 Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −11,950 41,700 D
Open-market sales · 11,950 sh · avg $62.16 · $742,838
Loading xslF345X05/edgardoc.xml…